{
    "2018-02-12": [
        [
            {
                "time": "",
                "original_text": "[买入评级]美年健康(002044)点评：公司发布业绩快报 平台化价值逐步强化",
                "features": {
                    "keywords": [
                        "美年健康",
                        "业绩快报",
                        "平台化价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]美年健康(002044)公司公告点评：2017年业绩高速增长 看好长期前景",
                "features": {
                    "keywords": [
                        "美年健康",
                        "2017年业绩",
                        "高速增长",
                        "长期前景"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "美年健康：慈铭体检并表增厚业绩 增持评级",
                "features": {
                    "keywords": [
                        "美年健康",
                        "慈铭体检",
                        "并表增厚业绩"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：市场震荡 投资机会显现",
                "features": {
                    "keywords": [
                        "医药生物",
                        "市场震荡",
                        "投资机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]美年健康(002044)业绩预览：业绩符合预期 看好长期发展",
                "features": {
                    "keywords": [
                        "美年健康",
                        "业绩预览",
                        "符合预期",
                        "长期发展"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}